Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...demic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
more
A STUDY OF THE CHALLENGES FACED BY PERSONS WITH DISABILITIES IN POST-EARTHQUAKE
NEPAL.
This paper brings together lessons from interviews with humanitarians and local responders, as well as existing literature, about the use of quarantine in urban environments during the humanitarian response to the Ebola Crisis
Review Article
Granich et al. Int J Virol AIDS 2018, 5:043 DOI: 10.23937/2469-567X/1510043 Volume 5 | Issue 1
Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek
http://www.who.int/disabilities/cbr/guidelines/en/
The equation is simple: we cannot effectively respond to a global pandemic when millions of people are still caught in warzones. We cannot treat sick people when hospitals are being bombed, or prevent the spread of coronavirus when tens of millions are forced to flee from violence. We must have a gl...obal ceasefire, and we must put our collective resources behind making that ceasefire a reality.
more
Explore best practise in pharmacy, and learn how to start a career as a pharmacist, with these online pharmacy courses from FutureLearn.
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
Regional Analysis. WPSAR Vol 7, No 2, 2016 | doi: 10.5365/wpsar.2015.6.4.010
Unofficial Translation
Approved by the Federal Government on October 20, 2016
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India